PCSA

Processa Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing drugs for patients with unmet medical needs in oncology and other therapeutic areas. The company employs a regulatory pathway strategy using its Next Generation Chemotherapy (NGC) platform to advance drug candidates through clinical development more efficiently. Processa has a pipeline of product candidates targeting various cancers and rare diseases. The company is based in Hanover, Maryland, and seeks to bring innovative treatments to market through partnerships and strategic development approaches.